cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast Cancer

Background: EGFR expression and pathway activation are common in triple-negative breast cancer (TNBC). However, anti-EGFR therapies have not been effective in these patients. We aimed to study the efficacy of targeting MET in overcoming resistance to EGFR therapy in TNBC cell lines. Methods: TNBC li...

Descripción completa

Detalles Bibliográficos
Autores principales: Sohn, Joohyuk, Liu, Shuying, Parinyanitikul, Napa, Lee, Jangsoon, Hortobagyi, Gabriel N., Mills, Gordon B., Ueno, Naoto T., Gonzalez-Angulo, Ana M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216798/
https://www.ncbi.nlm.nih.gov/pubmed/25368674
http://dx.doi.org/10.7150/jca.9696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216798/
https://www.ncbi.nlm.nih.gov/pubmed/25368674
http://dx.doi.org/10.7150/jca.9696

Ejemplares similares